Dr. Kyle Guidry, M.D

NPI: 1619960812
Total Payments
$9,961
2024 Payments
$1,214
Companies
58
Transactions
703
Medicare Patients
10,215
Medicare Billing
$586,299

Payment Breakdown by Category

Food & Beverage$9,913 (99.5%)
Education$48.17 (0.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $9,913 698 99.5%
Education $48.17 5 0.5%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $995.13 65 $0 (2024)
AstraZeneca Pharmaceuticals LP $945.24 48 $0 (2024)
Novo Nordisk Inc $834.59 66 $0 (2024)
GlaxoSmithKline, LLC. $831.27 55 $0 (2024)
PFIZER INC. $735.54 54 $0 (2024)
Lilly USA, LLC $642.99 53 $0 (2024)
Amgen Inc. $626.12 41 $0 (2024)
Merck Sharp & Dohme LLC $533.95 47 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $474.16 33 $0 (2024)
Allergan, Inc. $426.40 32 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,214 74 ABBVIE INC. ($311.93)
2023 $1,517 94 ABBVIE INC. ($371.99)
2022 $1,450 91 GlaxoSmithKline, LLC. ($214.41)
2021 $1,331 96 GlaxoSmithKline, LLC. ($251.72)
2020 $709.98 52 Allergan, Inc. ($182.83)
2019 $1,097 81 Amgen Inc. ($198.88)
2018 $1,375 111 Amgen Inc. ($201.76)
2017 $1,267 104 PFIZER INC. ($152.58)

All Payment Transactions

703 individual payment records from CMS Open Payments — Page 1 of 29

Date Company Product Nature Form Amount Type
12/30/2024 Seqirus USA Inc Fluad (Biological), Flucelvax Food and Beverage In-kind items and services $13.68 General
Category: Vaccines
12/10/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $21.46 General
Category: SCHIZOPHRENIA
12/05/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $22.62 General
Category: RESPIRATORY
12/03/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $5.17 General
Category: Diabetes
12/03/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $1.02 General
Category: Diabetes
11/21/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $6.31 General
Category: Diabetes
11/19/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $30.58 General
Category: NEUROSCIENCE
11/18/2024 Phadia US Inc. ImmunoCAP (Device) Food and Beverage Cash or cash equivalent $21.31 General
Category: Allergy/Immunology
11/15/2024 GlaxoSmithKline, LLC. SHINGRIX (Biological), AREXVY Food and Beverage In-kind items and services $16.88 General
Category: VACCINES
11/12/2024 Novo Nordisk Inc Saxenda (Drug), Wegovy Food and Beverage In-kind items and services $12.35 General
Category: Obesity
11/11/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $21.57 General
Category: Oncology
11/06/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $22.17 General
Category: VACCINE
11/04/2024 Kowa Pharmaceuticals America, Inc. ZORYVE (Drug) Food and Beverage In-kind items and services $16.82 General
Category: DERMATOLOGY
10/29/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $5.67 General
Category: Diabetes
10/28/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $29.15 General
Category: NEUROSCIENCE
10/03/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $7.79 General
Category: NEUROSCIENCE
09/25/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $6.03 General
Category: Diabetes
09/18/2024 Novo Nordisk Inc Saxenda (Drug), Wegovy Food and Beverage In-kind items and services $19.21 General
Category: Obesity
09/03/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $15.74 General
Category: Cardiovascular
08/29/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $13.36 General
Category: GASTROENTEROLOGY
08/28/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $19.58 General
Category: Diabetes
08/22/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $6.93 General
Category: Diabetes
08/22/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $0.22 General
Category: Diabetes
08/19/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $14.57 General
Category: Oncology
08/15/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $16.12 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 34 2,547 4,137 $294,374 $157,899
2022 38 2,683 4,191 $292,551 $159,524
2021 36 2,445 4,078 $281,000 $147,308
2020 38 2,540 4,039 $265,159 $121,568
Total Patients
10,215
Total Services
16,445
Medicare Billing
$586,299
Procedure Codes
146

All Medicare Procedures & Services

146 procedure records from CMS Medicare Utilization — Page 1 of 6

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 321 575 $54,050 $32,308 59.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 174 330 $28,710 $19,561 68.1%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 53 430 $26,363 $17,718 67.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 144 144 $21,600 $17,379 80.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 145 210 $31,290 $16,410 52.4%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 95 106 $21,306 $9,903 46.5%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 109 113 $12,430 $6,763 54.4%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 64 64 $5,440 $4,776 87.8%
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Office 2023 43 68 $5,576 $3,789 68.0%
99495 Transitional care management services for problem of at least moderate complexity Office 2023 16 18 $3,924 $2,727 69.5%
36415 Insertion of needle into vein for collection of blood sample Office 2023 199 322 $4,830 $2,688 55.7%
80061 Blood test, lipids (cholesterol and triglycerides) Office 2023 147 195 $10,725 $2,519 23.5%
0241U Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected Office 2023 17 18 $3,600 $2,516 69.9%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 16 16 $3,200 $2,487 77.7%
G0008 Administration of influenza virus vaccine Office 2023 65 65 $2,275 $1,884 82.8%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count Office 2023 170 241 $6,025 $1,826 30.3%
80053 Blood test, comprehensive group of blood chemicals Office 2023 141 176 $9,680 $1,811 18.7%
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg Office 2023 133 391 $6,647 $1,641 24.7%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 11 15 $1,875 $1,367 72.9%
84443 Blood test, thyroid stimulating hormone (tsh) Office 2023 49 70 $5,250 $1,152 21.9%
71046 X-ray of chest, 2 views Office 2023 43 50 $4,500 $1,152 25.6%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2023 23 27 $2,700 $876.35 32.5%
83036 Hemoglobin a1c level Office 2023 58 81 $5,265 $761.60 14.5%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2023 22 46 $2,162 $692.49 32.0%
G0103 Prostate cancer screening; prostate specific antigen test (psa) Office 2023 34 34 $2,210 $643.28 29.1%

About Dr. Kyle Guidry, M.D

Dr. Kyle Guidry, M.D is a Family Medicine healthcare provider based in Thibodaux, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619960812.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyle Guidry, M.D has received a total of $9,961 in payments from pharmaceutical and medical device companies, with $1,214 received in 2024. These payments were reported across 703 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($9,913).

As a Medicare-enrolled provider, Guidry has provided services to 10,215 Medicare beneficiaries, totaling 16,445 services with total Medicare billing of $586,299. Data is available for 4 years (2020–2023), covering 146 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Thibodaux, LA
  • Active Since 08/24/2005
  • Last Updated 06/29/2010
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1619960812

Products in Payments

  • VRAYLAR (Drug) $719.20
  • TRELEGY ELLIPTA (Drug) $619.08
  • FARXIGA (Drug) $615.11
  • ELIQUIS (Drug) $395.82
  • TRULICITY (Drug) $379.31
  • Ozempic (Drug) $374.96
  • JARDIANCE (Drug) $314.56
  • Aimovig (Biological) $285.43
  • Rybelsus (Drug) $257.88
  • UBRELVY (Drug) $253.46
  • JANUVIA (Drug) $236.73
  • Livalo (Drug) $234.44
  • INVOKANA (Drug) $227.35
  • Prolia (Biological) $199.06
  • XARELTO (Drug) $195.27
  • MOUNJARO (Drug) $155.25
  • XIFAXAN (Drug) $154.81
  • SYMBICORT (Drug) $147.69
  • CHANTIX (Drug) $147.17
  • QULIPTA (Drug) $146.39

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Thibodaux